ClearOne signs merger deal to acquire Cortigent, plans $10M-$15M capital raise
Seeking Alpha ·
ClearOne ( CLRO ) announced on Thursday that it signed a definitive merger agreement to acquire Vivani Medical ( VANI )'s unit Cortigent . After the deal closes, Cortigent will become a wholly owned subsidiary of ClearOne. The company plans to raise $10M-$15M through a Form S-1 financing alongside the transaction closing. This funding is expected to support the combined company's pipeline development. Chairman Eric Robinson said Cortigent's neurostimulation technology, aimed at helping patients recover sight and motor function, addresses significant unmet medical needs.
DYAX Investor Sentiment
Bullish (Long) 59% · Bearish (Short) 41%
465 participants
Related News
- 3 Core Artificial Intelligence (AI) Market Leaders to Buy with $1,000 Right Now and Hold for the Next 20 Years
- SA Asks: What's next for telecommunications stocks?
- Meta Could Hand Samsung Its Biggest AI Chip Order Yet in $6.5 Billion Deal
- Meta's AI Payoff Timeline Looks Messier
- Citi's Blockchain Pre-IPO Platform Trades Liquidity for Privacy, Polygon's Marc Boiron Says
- Why the Supreme Court's Ruling on the Fed This Week Is Good for the Stock Market